Daily Hot List: International Business Machines Corporation (NYSE:IBM), Conatus Pharmaceuticals (NASDAQ:CNAT), Acasti Pharma (NASDAQ:ACST), Vale S.A. (NYSE:VALE)

Gladstone Commercial Corp. (NASDAQ:GOOD) shares advanced 0.88% in last trading session and ended the day at $14.85. GOOD Gross Margin is 90.40% and its has a return on assets of 0.30%. Gladstone Commercial Corp. (NASDAQ:GOOD) quarterly performance is 7.19%.

On 7 December, Gladstone Commercial Corp. (NASDAQ:GOOD) announced that it sold three properties for gross proceeds of $6.9 million. The sales included the Company’s Birmingham, AL and Columbia, MO industrial buildings for gross proceeds of $4.1 million in December and the Company’s Columbus, OH industrial building for gross proceeds of $2.8 million in November. The combined sales will result in a gain of approximately $1.5 million.

International Business Machines Corporation (NYSE:IBM) shares fell -1.35% in last trading session and ended the day at $134.90. IBM Gross Margin is 50.30% and its has a return on assets of 12.60%. International Business Machines Corporation (NYSE:IBM) quarterly performance is -7.04%.

On 10 December, International Business Machines Corporation (NYSE:IBM) announced a collaboration agreement with the City of Johannesburg and Council for Scientific and Industrial Research (CSIR) to apply advanced technologies to help the City deliver on its air quality management plan.

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) caters to the Healthcare space. Its weekly performance is 7.94%. On the last day of trading company shares ended up at $2.99. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) distance from 50-day simple moving average (SMA50) is -11.00%.

Zacks Investment Research downgraded shares of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) from a buy rating to a hold rating in a report issued on Tuesday morning, Market Beat.com reports.

Acasti Pharma Inc. (NASDAQ:ACST) shares advanced 5.82% in last trading session and ended the day at $2.91. Acasti Pharma Inc. (NASDAQ:ACST) quarterly performance is -90.93%.

On 17 December, Acasti Pharma Inc. (NASDAQ:ACST) announced that it has received positive feedback from the FDA on the proposed development pathway for CaPre.

Vale S.A. (NYSE:VALE) caters to the Basic Materials space. It has a net profit margin of -10.40% and weekly performance is 1.59%. On the last day of trading company shares ended up at $3.20. Vale S.A. (NYSE:VALE) distance from 50-day simple moving average (SMA50) is -20.93%.

Vale S.A. (NYSE:VALE) said that, it will appeal a court decision to freeze some of it and BHP Billiton’s Brazilian assets, saying the ruling, which declared the two mining companies responsible for a dam burst last month, was “inappropriate.”

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *